Strides Pharma Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STRIDES PHARMA INTL
STRIDES PHARMA INTL has one hundred and ten approved drugs.
There are five US patents protecting STRIDES PHARMA INTL drugs.
Summary for Strides Pharma Intl
| US Patents: | 5 |
| Tradenames: | 75 |
| Ingredients: | 72 |
| NDAs: | 110 |
Drugs and US Patents for Strides Pharma Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma Intl | HALOPERIDOL | haloperidol | TABLET;ORAL | 071235-003 | Nov 3, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Strides Pharma Intl | IBUPROFEN | ibuprofen | TABLET;ORAL | 070330-001 | Aug 6, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Strides Pharma Intl | SUMYCIN | tetracycline hydrochloride | TABLET;ORAL | 061147-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Strides Pharma Intl | TRAMADOL HYDROCHLORIDE | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 078783-002 | Nov 13, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Strides Pharma Intl | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 074788-004 | Dec 29, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Strides Pharma Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Strides Pharma Intl | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,294,636 | ⤷ Start Trial |
| Strides Pharma Intl | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 5,583,152 | ⤷ Start Trial |
| Strides Pharma Intl | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-003 | Sep 17, 1999 | 4,859,692 | ⤷ Start Trial |
| Strides Pharma Intl | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,319,097 | ⤷ Start Trial |
| Strides Pharma Intl | ACCOLATE | zafirlukast | TABLET;ORAL | 020547-001 | Sep 26, 1996 | 5,583,152 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for STRIDES PHARMA INTL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 10 mg and 20 mg | ➤ Subscribe | 2008-02-29 |
International Patents for Strides Pharma Intl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2022001139 | ⤷ Start Trial |
| Brazil | 112022001591 | ⤷ Start Trial |
| Canada | 3148812 | ⤷ Start Trial |
| Japan | 2022544901 | ⤷ Start Trial |
| European Patent Office | 4003323 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Strides Pharma Intl Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1499331 | SPC/GB13/034 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313 |
| 1685839 | 92292 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| 0716606 | C300080 | Netherlands | ⤷ Start Trial | PRODUCT NAME: SEVELAMER, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SEVELAMER HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/99/123/001-00420000128 20000128 |
| 0984957 | C300483 | Netherlands | ⤷ Start Trial | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYFRAAT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20110524 |
| 0566709 | SPC/GB04/012 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
